Cinnamon for Blood Sugar

Cinnamon is one of the most beloved spices in the world and has attracted growing interest as a natural blood sugar support supplement. There is some evidence behind this use — but it comes with a crucial species distinction that is both a safety issue and a confounding factor in the clinical research: not all cinnamon is the same, and some types carry a genuine toxicity risk at supplement doses.

Two Very Different Cinnamons

The word "cinnamon" encompasses several distinct botanical species with different chemical profiles:

• Ceylon cinnamon (Cinnamomum verum): Also called "true cinnamon" or "soft cinnamon." Originates from Sri Lanka. Contains very low levels of coumarin (a hepatotoxic compound). Lighter flavour, more complex aroma. More expensive. This is considered the safer choice for regular supplementation.
• Cassia cinnamon (Cinnamomum cassia, C. aromaticum): The most commonly sold cinnamon in Irish supermarkets and most supplement capsules. Also sold as Chinese cinnamon. Contains high levels of coumarin — 1–12 mg per gram of dried cinnamon, versus less than 0.017 mg/g in Ceylon cinnamon. This distinction is not about flavour preference; it has real implications for liver safety at supplement doses.

The Coumarin Problem

Coumarin (not to be confused with warfarin, which is a synthetic coumarin derivative) is a naturally occurring compound with hepatotoxic potential. The European Food Safety Authority (EFSA) has established a tolerable daily intake (TDI) for coumarin of 0.1 mg/kg body weight per day. For a 70 kg adult, this is 7 mg/day.

A teaspoon of cassia cinnamon powder (approximately 2.6 g) can contain 5–7 mg of coumarin — approaching or meeting the TDI for a single serving. At typical cinnamon supplement doses (1–3 g/day), regular cassia cinnamon consumption provides coumarin at or above the TDI, which is associated with liver damage in susceptible individuals. European regulatory bodies have issued guidance specifically about this risk. Ceylon cinnamon does not present this concern at normal doses.

Blood Sugar Evidence

The clinical evidence for cinnamon and blood sugar is based primarily on cassia cinnamon, which is what most trials have used. A landmark 2003 paper by Khan et al. in Diabetes Care (n=60 type 2 diabetic patients) found that 1–6 g of cassia cinnamon powder daily for 40 days significantly reduced fasting blood glucose by 18–29%, triglycerides by 23–30%, LDL cholesterol by 7–27%, and total cholesterol by 12–26%. These were striking results that prompted substantial interest.

Subsequent meta-analyses have produced mixed findings. A 2012 Cochrane review found no clinically relevant effect on HbA1c (the gold standard diabetes control measure) from cinnamon in type 1 or type 2 diabetes. A 2013 meta-analysis by Allen et al. (Annals of Family Medicine) of 10 RCTs found cinnamon was associated with modest reductions in fasting blood glucose, total cholesterol, LDL cholesterol, and triglycerides — small but statistically significant effects.

A 2019 meta-analysis by Deyno et al. found cinnamon significantly reduced fasting blood glucose (by approximately 0.5–1.0 mmol/L) and HbA1c (by approximately 0.5%) in type 2 diabetes patients. These are modest but potentially clinically meaningful effects — comparable to the impact of dietary intervention.

The proposed mechanisms include insulin receptor sensitisation, inhibition of intestinal glucosidases (reducing carbohydrate absorption), and GLUT-4 transporter upregulation.

Evidence Summary

Practical Guidance: Choosing the Right Cinnamon

If using cinnamon supplementally or in meaningful daily quantities:

• Choose Ceylon cinnamon specifically (look for Cinnamomum verum or "true cinnamon" on the label)
• Most supermarket cinnamon powder and most cinnamon capsule supplements are cassia — check the Latin species name
• Ceylon cinnamon is available in most good Irish health shops and can be ordered online; it is typically more expensive and lighter in colour with a finer texture
• For culinary use in normal cooking quantities, either type is of low concern. The issue arises with supplement doses or large daily medicinal quantities of cassia

Safety & Interactions

Diabetes medication: Cinnamon may lower blood glucose and can have additive effects with insulin or oral hypoglycaemic agents, potentially causing hypoglycaemia. People with diabetes on medication should discuss cinnamon supplementation with their GP or diabetes care team and monitor blood glucose carefully.

Anticoagulants: Cinnamon has mild anticoagulant properties. People on warfarin should be aware of potential additive effects; monitor INR and discuss with your GP or anticoagulation clinic.

Liver conditions: Due to the coumarin content of cassia cinnamon, people with existing liver disease should avoid supplemental cassia cinnamon. Ceylon cinnamon is the appropriate choice if liver health is a concern.

Allergy: Cinnamon allergy (cinnamate sensitivity) exists; it can cause contact dermatitis in topical applications and oral allergy reactions with oral use. People with known cinnamon sensitivity should avoid.

Pregnancy: Cinnamon in cooking is safe in pregnancy. Large supplemental doses should be avoided due to potential uterine stimulant effects and insufficient safety data. Do not use cinnamon supplements to attempt to manage gestational diabetes without medical supervision.

The Verdict

Cinnamon has moderate evidence for modest blood sugar reduction in type 2 diabetes, which is biologically plausible and supported by multiple meta-analyses, though the effect sizes are not dramatic. The critical practical point is the cassia versus Ceylon distinction — at supplement doses, cassia cinnamon carries a real coumarin-related liver risk that Ceylon does not. Anyone using cinnamon regularly as a supplement should choose Ceylon (Cinnamomum verum) specifically. Blood sugar management in diabetes is a serious medical matter that requires GP supervision; cinnamon is at best a modest dietary adjunct within a broader management plan.